FDA Inspection 1245256 — Foshan Nanhai Zhongnan Pharmaceutical Factory
The FDA completed an inspection of Foshan Nanhai Zhongnan Pharmaceutical Factory on Sep 6, 2024 in Nanhai, Foshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 6, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanhai, Foshan (China)